Latest Breaking News On - Cancerous pain - Page 1 : comparemela.com

Share this article Share this article ATHENS and TEL AVIV, Israel, May 19, 2021 /PRNewswire/ Panaxia Labs Israel, Ltd. (Panaxia Israel) (TASE: PNAX), Israel s leading medical cannabis products manufacturer and Leriva Group, one of Greece s leading distributors of medical equipment, medical supplies and health services, announced today, Wednesday May 19, 2021, a binding agreement of manufacture, commercialization and distribution of medical cannabis finished products, developed by Panaxia for medical cannabis patients in Greece. Under the agreement, Panaxia will be responsible for registering the products, while complying with the European standard requirements, including EU-GMP; developing and manufacturing new and advanced products, including tablets, suppositories (candles) and inhalation products.

United statesTel avivDadi segalGeorge joakimidisPrnewswire panaxia labs israel ltdSegal pharma groupEu health authorityPanaxia groupPanaxia pharmaceutical industriesTel aviv stock exchangeLeriva groupLabs israelPanaxia israelWednesday mayNeuropathic painCancerous pain